Research Article

Clinical Characteristics of Turkish Women with Candida krusei Vaginitis and Antifungal Susceptibility of the C. krusei Isolates

Table 2

Basic clinical characteristics of women with vaginal complaints in the study.

VariablesC.  krusei (%)
PresentAbsentTotal

Diabetes mellitus
 Absent21 (1.7)1,250 (98.3)1,2710.21
 Present7 (2.6)265 (97.4)272
Hypothyroidism
 Absent26 (1.8)1,452 (98.2)1,4780.31
 Present2 (3.2)60 (96.8)62
Hyperthyroidism
 Absent26 (1.7)1,478 (98.3)1,5040.15
 Present2 (5.3)36 (94.7)38
Other chronic diseases
 Absent 19 (1.7)1,127 (98.3)1,1460.28
 Present9 (2.3)387 (97.7)396
Medication other than antibiotics
 Absent  22 (2.0)1,056 (98.0)1,0780.22
 Present6 (1.3)458 (98.7)464
Use of local steroid in the last 4 weeks
  Absent 27 (1.8)1,492 (98.2)1,5190.35
  Present1 (4.3)22 (95.7)23
Use of systemic steroid in the last 4 weeks
  Absent 28 (1.9)1,482 (98.1)1,5100.57
  Present0 (0.0)30 (100.0)30
Perineal laceration
  Absent 15 (1.3)1,163 (98.7)1,1780.006
  Present13 (3.6)351 (96.4)364
Contraception
 None9 (1.4)637 (98.6)6460.49
 OC1 (1.0)103 (99.0)104
 IUD8 (2.9)268 (97.1)276
 Condom4 (1.5)258 (98.5)262
 Others6 (2.4)248 (97.6)254
Personal allergic history
 Absent 24 (1.8)1,316 (98.2)1,3400.51
 Present 4 (2.0)197 (98.0)201
History of sexual intercourse in the last 4 weeks
 Present8 (2.8)279 (97.2)2870.13
 Absent20 (1.6)1,235 (98.4)1,255
Antibiotic use in the last 4 weeks
  Absent 27 (2.1)1,260 (97.9)1,2870.07
  Present1 (0.4)254 (99.6)255
Body mass index
 ≤191 (2.3)42 (97.7)430.4
 19–244 (1.1)369 (98.9)373
 24–299 (1.6)561 (98.4)570
 >2914 (2.5)540 (97.5)554

OC: oral contraceptive; IUD: intrauterine device.